comparemela.com

Latest Breaking News On - Anas younes - Page 5 : comparemela.com

Calquence reduced risk of disease progression or death by 71% vs standard of care combinations

Updated results from the ASCEND Phase III trial showed AstraZeneca’s Calquence (acalabrutinib) maintained a statistically significant progression-free

AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021

Taking on New Challenges: 8 Questions with Gilles Salles

Summary Meet Lymphoma Service Chief Gilles Salles, who recently joined MSK after a long career in France. Gilles Salles recently joined Memorial Sloan Kettering as Chief of the Lymphoma Service within the Division of Hematologic Malignancies. Dr. Salles came to MSK after a long career at Claude Bernard University in Lyon, France. In an interview conducted in early December just before the annual American Society of Hematology (ASH) meeting, where he presented updates from several studies he’s conducted, Dr. Salles spoke about his decision to join MSK, his research, and his plans for the Lymphoma Service. Why did you decide to come to MSK?

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.